Changes in systemic vascular endothelial growth factor levels after intravitreal injection of aflibercept in infants with retinopathy of prematurity.
Journal:
Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie
PMID:
29290015
Abstract
BACKGROUND: To investigate the levels of VEGF in the systemic circulation of patients with type 1 ROP who received intravitreal injections of 1 mg (0.025 mL) aflibercept (IVA) or 0.625 mg (0.025 mL) bevacizumab (IVB).
Authors
Keywords
Angiogenesis Inhibitors
Biomarkers
Dose-Response Relationship, Drug
Enzyme-Linked Immunosorbent Assay
Female
Follow-Up Studies
Humans
Infant, Newborn
Intravitreal Injections
Male
Prognosis
Prospective Studies
Receptors, Vascular Endothelial Growth Factor
Recombinant Fusion Proteins
Retinopathy of Prematurity
Time Factors
Treatment Outcome
Vascular Endothelial Growth Factors